LEVOCETIRIZINE 2.5mg. IP + MONTELUKAST SODIUM 4mg. IP

An antiallergic medication is indicated for the relief of symptoms of allergic rhinitis (seasonal and perennial). Provides symptomatic of allergic rhinitis, chronic idiopathic urticaria, and obstructive airway diseases. Has a dual mechanism of action and acts both as a bronchodilator and anti-inflammatory agent. (Mohini Sachin Mahatme, 2016) A more effective approach than monotherapy in the treatment of persistent allergic rhinitis. (S M Adsule, 2010) Significantly alleviates nasal symptoms associated with persistent allergic rhinitis. (Maciej Ciebiada, 2011) An effective antihistamine for treating influenza, common cold, and acute inflammation. (Bhattacharyya, 2020) A beneficial medication that eases symptoms of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. (Devada Singh-Franco, 2009) An effective and safe therapeutic option in treating perennial allergic rhinitis patients with asthma compared with montelukast alone. (Mi-Kyeong Kim, 2018) Ameliorates the naso-ocular symptoms and health-related quality of life in seasonal allergic rhinitis. (Nathan Segall, 2010)